The IIHMR University has been established by Government of Rajasthan vide the IIHMR University Ordinance, 2013 (Ordinance No 30 of 2013) promulgated on September 27,2013 by the Governor which was replaced by the IIHMR University Act, 2014 (Act No.3, of 2014) passed by the State Legislature on February 07, 2014. The Act of 2014 received the assent of the Governor on 25th day of February, 2014 and was finally notified in Rajasthan Gazette Extraordinary on February 26,2014.
Showing posts with label MBA Health & Hospital. Show all posts
Showing posts with label MBA Health & Hospital. Show all posts
Thursday, 5 November 2015
Monday, 5 January 2015
Pharmacovigilence in Healthcare
IIHMR University conducted a Management Development Programme on Pharmacovigilence in Healthcare from 15-19 December 2015. It was a Five day program which started on 15 dec 2014 and concluded on 19 dec 2014 at Indian Institute of Health Management and Research University
World Health Organization defines Pharmacovigilance as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicinerelated problem.
Once drugs are into the market, a medicine leaves the secure and protected scientific environment of clinical trials and is legally set free for consumption by the general population. At this point, most medicines will only have been tested for short-term safety and efficacy on a limited number of carefully selected individuals. Understanding different aspects of Pharmacovigilance is important as it is essential that new and medically still evolving treatments are monitored for their effectiveness and safety under real-life conditions post release.
The aim of the course is to strengthen participants with concepts and current practices in Pharmacovigilance.
The aim of the course is to strengthen participants with concepts and current practices in Pharmacovigilance.
OBJECTIVES
OF THE PROGRAM
- To understand different aspects of Pharmacovigilance in practice
- To prepare for Pharmacovigilance audit preparation & regulatory inspection
- To understand issues regarding risks and benefits of drug use in humans including the cause, manifestations and consequences of adverse drug effects (ADEs).
- To understand about detection and monitoring of the ADR.
- To introduce participants to fundamental statistical, compliance and regulations concepts and methods.
KEY
CONTENTS
- Adverse event (AE) definition & reporting
- Causality assessment of adverse event
- Risk Management
- Compliance to Clinical Safety
- Expectedness assessment of an adverse event
- Medical Dictionary, Drug coding, Unbinding & reporting
- Issue work-up of aggregate data-consideration of preclinical, clinical, epidemiological, safety database, aggregate analysis
- Design of Post marketing studies
- Global Pharmacovigilance Regulations, ICH, EMEA, US FDA directives
- Periodic Surveillance Update Report/ Annual Safety Report
- National Pharmacovigilance Program
- Management and Importance of Pharmacovigilance
Subscribe to:
Posts (Atom)


